Avendus Advises Windlas Healthcare on 51% Stake Acquisition by Cadila Healthcare

We are excited to have Cadila Healthcare as a partner in our journey, particularly in regulated pharmaceutical markets.  We believe that our capabilities in R&D, manufacturing and compliance, coupled with Cadila’s experience and reputation will be a great combination. The pharmaceuticals landscape in these markets is changing rapidly and this relationship will surely help the company achieve its planned objectives.

Windlas Healthcare has created a nimble organization with focused product development capabilities and strong manufacturing compliance standards. This partnership will allow Windlas Healthcare to continue to leverage the company’s strengths and benefit from the experience and track record of Cadila Healthcare to drive value creation for all stakeholders